FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Elan topics
Folic Acid
Carbon Dioxide
Antibodies
Immune Response
High Energy
Inorganic Compounds
Electrolysis
Semiconductor Material
Semiconductor
Hydrogen Production From Water
Female Sexual Dysfunction
Dysfunction
Sexual Dysfunction
Mammography
Radiograph

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Elan patents



      
           
This page is updated frequently with new Elan-related patent applications. Subscribe to the Elan RSS feed to automatically get the update: related Elan RSS feeds. RSS updates for this page: Elan RSS RSS


Date/App# patent app List of recent Elan-related patents
04/23/15
20150112116
 Tyrosine derivatives and compositions comprising them patent thumbnailnew patent Tyrosine derivatives and compositions comprising them
Provided herein are methods comprising providing a tyrosine derivative and a solid particulate material (and, optionally, melanin) and applying force to said tyrosine derivative and said solid particulate material for a time and under conditions effective to impregnate at least one of said tyrosine derivative and said solid particulate material with the other of said tyrosine derivative and said solid particulate material. The invention also provides compositions comprising at least one of a tyrosine derivative impregnated with a solid particulate material and a solid particulate material impregnated with a tyrosine derivative..
04/23/15
20150111969
 J-series prostaglandin-ethanolamides as novel therapeutics patent thumbnailnew patent J-series prostaglandin-ethanolamides as novel therapeutics
A pharmaceutical composition comprising the compound of formula (i), a pharmaceutical composition comprising anandamide (aea) and methods of using the same in the treatment of non-melanoma skin cancer (nmsc) and colorectal cancer.. .
04/23/15
20150111904
 Pharmaceutical combination of mek inhibitor and b-raf inhibitors patent thumbnailnew patent Pharmaceutical combination of mek inhibitor and b-raf inhibitors
A novel combination comprising the mek inhibitor n-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)6,8-dimethyl;-2,4,7-trioxo-3,4,6,7-tetrahydro-2h-pyrido[4,3-d]pyrimidin-1-yl]phenyl}acetamide, or solvate thereof, with a b-raf inhibitor, particularly n-{3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the same and methods of using such combinations and compositions in the treatment of conditions in which the inhibition of mek and/or b-raf is beneficial, eg. Melanoma..
Glaxosmithkline Llc
04/23/15
20150111808
 Laundry treatment composition comprising a shading dye and chelant patent thumbnailnew patent Laundry treatment composition comprising a shading dye and chelant
B. A chelating agent..
04/23/15
20150110725
 Mixture for the inhibition of melanin biosynthesis patent thumbnailnew patent Mixture for the inhibition of melanin biosynthesis
The present invention relates to a mixture comprising acetylglucosamine and 4-(1-phenylethyl)-1,3-benzenediol for use as a cosmetic and/or medicament, and particularly for the inhibition of melanin biosynthesis, and to a cosmetic and/or pharmaceutical formulation comprising such a mixture for the treatment of hyperpigmented lesions of the skin such as, for example but without limitation, lentigo solaris, age spots, melasma and chloasma, for rendering uniform the color of the skin, for counteracting the formation of free radicals, and for counteracting or preventing signs of skin aging such as wrinkles and lack of skin tone, and generally for improving the aesthetic conditions of the skin.. .
General Topics S.r.l.
04/16/15
20150105251
 Composition comprising a biological control agent and a fungicide selected from inhibitors of the lipid membrane synthesis, the melanine biosynthesis, the nucleic acid synthesis or the signal transduction patent thumbnailComposition comprising a biological control agent and a fungicide selected from inhibitors of the lipid membrane synthesis, the melanine biosynthesis, the nucleic acid synthesis or the signal transduction
The present invention relates to a composition comprising at least one biological control agent. Furthermore, the present invention relates to the use of this composition as well as a method for reducing overall damage of plants and plant parts..
Bayer Cropscience Ag
04/09/15
20150099737
 Pyrrolopyrimidine compounds as inhibitors of cdk4/6 patent thumbnailPyrrolopyrimidine compounds as inhibitors of cdk4/6
The invention is directed to novel pyrrolopyrimidine compounds of formula (1) wherein r1, r2y, r4, r8-r11, a and l are defined herein and to salts, including pharmaceutically acceptable salts thereof. The compounds of the present invention are cdk4/6 inhibitors and could be useful in the treatment of diseases and disorders mediated by cdk4/6, such as cancer, including mantle cell lymphoma, liposarcoma, non small cell lung cancer, melanoma, squamous cell esophageal cancer and breast cancer.
Novartis Ag
04/09/15
20150098898
 Pharmaceutical composition, method and kit for detecting human melanoma cells patent thumbnailPharmaceutical composition, method and kit for detecting human melanoma cells
The present disclosure is related to a pharmaceutical composition for detecting human melanoma cells, including: a liposome, a biomolecule having specificity for αvβ3 integrin and a radionuclide. The present disclosure also provides a method using the pharmaceutical composition for detecting human melanoma cells and a kit performing the method.
Institute Of Nuclear Energy Research Atomic Energy Council, Executive Yuan
04/02/15
20150093342
 Method to protect skin from ultraviolet radiation using novel peptides involved in the improvement of microparasol organization in keratinocytes patent thumbnailMethod to protect skin from ultraviolet radiation using novel peptides involved in the improvement of microparasol organization in keratinocytes
The invention relates to cosmetic methods for improving the microparasol organization in keratinocytes, protecting skin against ultraviolet radiation, decreasing dna photodamage in keratinocytes and melanocytes, attenuating age-related pigmentation defects and the effects of photoaging on the skin. The methods include applying a composition comprising a peptide compound of general formula (i), r1-(aa)n-x1—x2—x3-asp-leu-lys-lys-x4—x5-(aa)p-r2, and a cosmetically acceptable medium..
Isp Investments Inc.
03/26/15
20150087856
 Melanin production inhibitor patent thumbnailMelanin production inhibitor
The present invention provides a melanin production inhibitor containing a compound having a (2-isopropyl-5-methyl)cyclohexyl group or a (2-isopropenyl-5-methyl)cyclohexyl group.. .
Takasago International Corporation
03/26/15
20150087564

Novel enhancing fracture conductivity


Propping compositions comprising: a hardenable, liquid external phase comprising an element selected from the group consisting of: a cement, a cement foam, a polymer, a resin, an aluminum, a flowable carrier fluid, and any combination thereof; and an internal phase that is either gas or liquid and that is immiscible with the external phase; wherein the internal phase exits the propping composition as the hardenable external phase hardens, leaving behind an hardened, interconnected porous network. Some propping compositions may require contact with a treatment for removal from the hardenable external phase and the treatment for removal may comprise at least one material selected from the group consisting of: an acid, a base, a chelant, an oxidizer, a solvent, and any combination thereof..
Halliburton Energy Services, Inc.
03/26/15
20150086615

Sterol derivatives and use thereof for treating diseases involving transformed astrocyte cells or for treating malignant haemopathies


Novel sterol derivatives, the preparation method thereof, pharmaceutical compositions containing them and use thereof for treating diseases involving transformed astrocyte cells or for treating malignant haemopathies. The treatment of glioblastoma multiforme, as well as of other cancers, such as lymphomas, neuroblastomas and melanomas is also described..
Beta Innov
03/26/15
20150086513

Method for deriving melanocytes from the hair follicle outer root sheath and preparation for grafting


The present invention relates to the field of biology and medicine, and more specifically, to the field of stem-cell biology, involving producing or generating melanocytes from stem-cells and precursors derived from human hair root. Additionally, the present invention relates to the materials and method for producing autografts, homografts or allografts comprising melanocytes in general, as well as the materials and methods for producing autografts, homografts and allografts comprising melanocytes for the treatment of diseases related to depigmentation of the skin and for the treatment of scars..
Universitat Leipzig
03/19/15
20150080412

Triazolone compounds and uses thereof


The invention disclosed herein is directed to compounds of formula (i) and pharmaceutically acceptable salts thereof, which are useful in the treatment of prostate, breast, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention also comprises pharmaceutical compositions comprising a therapeutically effective amount of compound of formula (i), or a pharmaceutically acceptable salt thereof.
Inception 2, Inc.
03/19/15
20150080372

Compounds and methods for kinase modulation, and indications therefor


Compounds and salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof and uses thereof are described. In certain aspects and embodiments, the described compounds or salts thereof, formulations thereof, conjugates thereof, derivatives thereof, forms thereof are active on each of b-raf, b-raf v600e and c-raf-1 protein kinase.
Plexxikon Inc.
03/19/15
20150079000

Labelled quinoxaline derivatives as multimodal radiopharmaceuticals and their precursors


The present invention relates to the compound of formula (i), in which r1 represents sn(r)3, b(oh)2, b(or)2, a halogen atom, no2, a radionuclide or a —n+(r)3 group, where r is a (c1-c6) alkyl group, r2 represents a hydrogen atom or a (c1-c6)alkyl group, r3 represents: a —(ch2ch2o)n2—(ch2)n3—x group, or a —(ch2ch2o)n4—(ch2)n5—y group with y representing a —c═c—h, a —n3 or a —ar—(ch2)n6—(och2ch2)n7—x group, and x represents a halogen atom, a radionuclide or a —oso2r′ group, where r′ is a cf3, ch3, t-bu, ph, p-no2ph, p-brph or p-ch3ph group, and their addition salts with pharmaceutically acceptable acids, the present invention also relates to pharmaceutical compositions comprising them and to their use in diagnosis, in particular with spect or pet imaging and in therapy of melanoma, via targeted radionuclide therapy.. .
Universite D'auvergne Clermont I
03/19/15
20150078123

Synthetic underwater visualization system


A synthetic underwater visualization system (suvs) comprising a real-time graphics software engine, a sophisticated underwater environmental sensor, a fixed-base database, and a retrieval system designed to accept and assimilate into a common database bathymetric and environmental information acquired from around the world by components of other deployed suvs sensing systems. Suvs is capable of sensing, modeling, and realistically displaying underwater environments in real-time, and will foster widespread utilization in the areas of homeland security, commercial and recreational maritime navigation, bathymetric data collection, and environmental analysis.
Appareo Systems, Llc
03/12/15
20150073053

Treatment of drug resistant cancer


The present invention discloses novel agents and methods for diagnosis and treatment of melanoma. Also disclosed are related arrays, kits, and screening methods..
Rockefeller University (the)
03/05/15
20150065691

Anti-cancer antibodies with reduced complement fixation


The invention provides modified antibodies directed against gd2 that have diminished complement fixation relative to antibody-dependent, cell-mediated cytotoxicity, which is maintained. The modified antibodies of the invention may be used in the treatment of tumors such as neuroblastoma, glioblastoma, melanoma, small-cell lung carcinoma, b-cell lymphoma, renal carcinoma, retinoblastoma, and other cancers of neuroectodermal origin..
Merck Patent Gmbh
03/05/15
20150065646

Molasses binder


A binder based predominantly on molasses which incorporates both polymeric and monomeric polycarboxylic acid components to form a composite including both melanoidin and polyester polymeric structures. The binder incorporates the chemical profile of molasses with a mixture of polycarboxylic acids which combines to form a strong and weatherable binder composition which may be used to bind loosely or non-assembled matter..
Knauf Insulation
03/05/15
20150064255

Nanostructures for treating cancers and other conditions


Nanostructures, compositions and methods for treating cancers and other conditions are provided. In some cases, the nanostructures and/or compositions may be used to treat cancers or other diseases or conditions at least in part by controlling cholesterol metabolism in cells.
Northwestern University
03/05/15
20150064180

Combination therapy with cd4 lymphocyte depletion and mtor inhibitors


The invention provides methods for treating a malignant neoplastic cell proliferative disorder or disease, comprising administering to a subject in need thereof an effective amount of an mtor inhibitor and an effective amount of a cd4 lymphocyte depleting agent. Such methods find utility in the treatment of certain subsets of malignant neoplastic cell proliferative disorders or diseases, e.g.
Cedars-sinai Medical Center
02/26/15
20150057668

Joint distraction device for arthroscopic surgery


A joint distraction device for use in an arthroscopic surgery is provided. The device has a joint distraction mechanism, situated in between two bone fixation surfaces, and is capable of changing the relative distance between these two surfaces.
The Board Of Trustees Of The Leland Stanford Junior University
02/26/15
20150057552

Methodology for determining concentration of the types of melanin pigment in the skin


The present invention relates generally to a methodology of determining the concentration of the types of melanin, either eumelanin or pheomelanin, in the skin wherein the process for such determination is non-invasive and based on digital signal and image analysis of hyperspectral sensing and multi-spectral data.. .
Institute Of Technology Petronas Sdn Bhd
02/26/15
20150057550

Robotic imaging system


A robotic imaging system has at least one robotic imaging arm that includes a free-space optics subsystem. The free-space optics is capable of conveying an excitation light signal through the robotic imaging arm to an optical end effector at the distal end thereof while maintaining coaxial alignment between the optical axis and the robotic skeleton.
The Board Of Trustees Of The Leland Stanford Junior University
02/26/15
20150057549

Live being optical analysis system and approach


Analysis of live beings is facilitated. According to an example embodiment of the present invention, a light-directing arrangement such as an endoscope is mounted to a live being.
The Board Of Trustees Of The Leland Stanford Junior University
02/26/15
20150057431

Compositions for treating a disease or condition associated with abnormal angiogenesis


The present invention provides methods of treating (including preventing) a disease or condition associated with abnormal angiogenesis in a subject include administering a therapeutically effective amount of an aa targeting compound of the invention to the subject. The aa targeting compounds comprise aa targeting agent-linker conjugates which are linked to a combining site of an antibody..
Covx Technologies Ireland Ltd.
02/26/15
20150057357

Bis (thiohydrazide amide) compounds for treating cancers


Methods of treating a subject with cancer characterized by an impaired ability to repair oxidative dna damage, comprising administering to the subject an effective amount of a bis(thiohydrazide amide) compound are provided.. .
The Board Of Trustees Of The Leland Stanford Junior University
02/26/15
20150057305

Pharmaceutical composition


Disclosed in the present invention is a pharmaceutical composition, comprising a weight ratio of 1:120 to 1:1000 of camptothecin compound of formula i and β-cyclodextrin or derivatives thereof, and an acidic buffer to adjust the ph=3.5-6.0. The composition can be used to treat solid tumours, such as melanoma, pancreatic cancer, hepatoma etc.
Shanghai Hotmed Sciences Co., Ltd.
02/26/15
20150057267

Methods and compositions for treating viral diseases


The invention provides a method for treating viral infections and coinfections through the use of inhibitory agents that prevent a unique viral structural protein motifs from binding to host proteins from the clathrin adaptor proteins family and subsequently preventing viral replication.. .
The Board Of Trustees Of The Leland Stanford Junior University
02/26/15
20150057189

In vivo transduction with a chimeric aav capsid protein


Recombinant adeno-associated viral (aav) capsid proteins are provided. Methods for generating a library of recombinant adeno-associated viral capsid proteins are also provided..
The Board Of Trustess Of The Leland Stanford Junior University
02/26/15
20150057154

Herbicidal compositions comprising sulfentrazone plus propyzamide and sulfentrazone plus propyzamide plus ethalfluralin


Provided herein are herbicidal compositions containing (a) sulfentrazone and (b) propyzamide and (a) sulfentrazone and (b) propyzamide and (c) ethalfluralin. The compositions provide synergistic weed control of undesirable vegetation, e.g., in wheat, barley, oats, rye, sorghum, corn or maize, oilseed rape, mustard crops, soybeans, vegetables, pulse crops (e.g., common bean, field pea, chickpea, lentil and faba bean), pastures, grasslands, rangelands, fallow land, turf, tree and vine orchards, industrial vegetation management or rights-of-way..
Dow Agrosciences Llc
02/26/15
20150056938

Method and system for characterising a frequency translating device


The present invention relates to a method for characterizing at a given frequency reflected waves of a frequency translating device having at least two ports, whereby information is available on the phase of a local oscillator driving the frequency translating device. The method comprises the steps of—applying at the at least two ports at least a tone at said given frequency and tones at said given frequency offset by the local oscillator signal frequency,—rotating the phase of the applied tone at said given frequency or exploiting a phase rotation of the local oscillator signal,—measuring at said given frequency amplitude and phase of reflected waves at the at least two ports and measuring at said given frequency and at said given frequency offset by the frequency of the local oscillator signal amplitude and phase of incident waves at the at least two ports,—determining parameters for a model of the frequency translating device by relating the amplitude and phase of the reflected waves to the incident waves, taking into account at least the local oscillator signal phase..
National Instruments Ireland Resources Limited
02/26/15
20150056435

Transparent conducting electrodes comprising mesoscale metal wires


A composition suitable for use in a transparent conducting electrode (tce) is disclosed. The composition comprises a conductive background medium and an incorporated plurality of mesoscale metal wires.
The Board Of Trustees Of The Leland Stanford Junior University
02/26/15
20150056287

Nanoparticulate megestrol formulations


The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm..
Alkermes Pharma Ireland Limited
02/26/15
20150056286

Nanoparticulate megestrol formulations


The present invention is directed to nanoparticulate compositions comprising megestrol. The megestrol particles of the composition have an effective average particle size of less than about 2000 nm..
Alkermes Pharma Ireland Limited
02/26/15
20150056230

Equine encephalitis virus vaccines and methods of using thereof


Disclosed herein are nucleotide sequences which encode a plurality of structural proteins, except the capsid, of an equine encephalitis virus, wherein the nucleotide sequence is codon-optimized for mammalian expression. The nucleotide sequences are codon-optimized for expression in humans.
02/26/15
20150056218

P97 fragments with transfer activity


The present invention is related to fragments of human melanotransferrin (p97). In particular, this invention relates to treatment of diseases through the introduction of the melanotransferrin fragment conjugated to a therapeutic or diagnostic agent to a subject..
Bioasis Technologies, Inc.
02/26/15
20150056213

Selective histone deactylase 6 inhibitors


Disclosed are selective histone deactylase inhibitors (hdaci) that having formula (i). Methods of making and using these inhibitors for the treatment of cancer, in particular melanoma are also disclosed..
Board Of Trustees Of The University Of Illinois
02/26/15
20150056162

Therapeutic il-13 polypeptides


Variant il-13 polypeptides are provided, which are engineered to have one or more of the following properties: (a) altered affinity for il-13rα2, relative to the native human il-13 protein; (b) altered affinity for il-13rα1 relative to the native human il-13 protein; (c) a disruption in the binding site for il-4rα relative to the native human il-13 protein.. .
The Board Of Trustees Of The Leland Stanford Junior University
02/26/15
20150056142

Near-infrared-ii fluorescent agents, methods of making near-infrared-ii fluorescent agents, and methods of using water-soluble nir-ii fluorescent agents


Embodiments of the present disclosure provide for compositions including organic, water-soluble nir-ii fluorescent agent that emit radiation at about 1.0 to 1.7 μm, methods of making the composition, methods of imaging a disease and related biological events, methods of imaging, monitoring and/or assessing a disease and related biological events, and the like.. .
The Board Of Trustees Of The Leland Stanford Junior University
02/26/15
20150056137

Caspase-triggered nano-aggregation probes and methods of use


Provided is an activatable probe that undergoes intramolecular cyclization and subsequent aggregation in apoptotic tumor cells upon peptidase-initiated, and most advantageously caspase-3, activation. These caspase-sensitive nano-aggregation probes (c-snafs) are generally biocompatible, possess nir spectral properties or may serve as pet or mri imaging agents, and have a mechanism of target-mediated nanostructure self-assembly amenable to in vivo use.
The Board Of Trustees Of The Leland Stanford Junior University
02/26/15
20150056099

Diagnostic radio frequency identification sensors and applications thereof


An integrated passive wireless chip diagnostic sensor system is described that can be interrogated remotely with a wireless device such as a modified cell phone incorporating multi-protocol rfid reader capabilities (such as the emerging gen-2 standard) or bluetooth, providing universal easy to use, low cost and immediate quantitative analyses, geolocation and sensor networking capabilities to users of the technology. The present invention can be integrated into various diagnostic platforms and is applicable for use with low power sensors such as thin films, mems, electrochemical, thermal, resistive, nano or microfluidic sensor technologies.
Altivera, Llc


Popular terms: [SEARCH]

Elan topics: Folic Acid, Carbon Dioxide, Antibodies, Immune Response, High Energy, Inorganic Compounds, Electrolysis, Semiconductor Material, Semiconductor, Hydrogen Production From Water, Female Sexual Dysfunction, Dysfunction, Sexual Dysfunction, Mammography, Radiograph

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Elan for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Elan with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         













0.2723

3195

1 - 1 - 76